期刊文献+

骨桥蛋白和P21在原发性肝癌中的表达及其临床意义 被引量:7

Expression of osteopontin and P21 in primary hepatic carcinoma and their clinical significance
下载PDF
导出
摘要 目的 探讨骨桥蛋白(OPN)和P2 1在原发性肝癌组织中的表达及它们在肝癌转移中的作用。方法 采用免疫组化S P法检测69例原发性肝癌组织中OPN和P2 1的表达情况。结果 ①OPN和P2 1的阳性表达主要定位于癌细胞的细胞浆;OPN、P2 1在69例肝癌组织中阳性表达率分别为72 .5 % (5 0 / 69)和62 .3 % (4 3 / 69)。②在发生转移的肝癌组织中OPN和P2 1阳性表达率分别为84.2 % (3 2 / 3 8)和76.3 % (2 9/ 3 8) ,高于无转移的肝癌组织中OPN(5 8.1% ,18/ 3 1)和P2 1(4 5 .2 % ,14 / 3 1)阳性表达率,差异具有显著性,P <0 .0 5。③两者均阳性表达的3 5例肝癌中有2 4例(74.3 % )已发生转移,与两者均阴性表达的11例肝癌中仅有1例(9.1% )发生转移比较差异有显著性,P <0 .0 5 ,提示OPN和P2 1均阳性表达与肿瘤转移的发生密切相关。④OPN和P2 1的表达与肿瘤的大小、AFP水平、有无HBV感染、肿瘤分化、性别、年龄等因素无关,但与肿瘤侵袭转移的发生有关,P <0 .0 5。⑤OPN和P2 1的表达呈显著正相关(r =0 .2 5 7,P <0 .0 5 )。结论 OPN和P2 1的表达与肝癌侵袭转移的发生有密切关系,两者均阳性表达时对预测肝癌已发生转移具有指导意义。 Objective To investigate the expression of osteopontin (OPN) and P21 in primary hepatic carcinoma(PHC) tissue.Methods Expression of OPN and P21 in primary hepatic carcinoma tissues from 69 patients with primary hepatic carcinoma were detected using SP immunohistochemical technique. Results OPN and P21 expression was mainly located in the cytoplasm of PHC cell. The positive rates of OPN and P21 in primary hepatic carcinoma tissues were 72.5% and 62.3%,respectively.The positive rates of OPN and P21 in primary hepatic carcinoma tissues with metastasis were 84.2%(32/38)and 76.3%(29/38),respectively, which were higher than that in primary hepatic carcinoma tissues without metastasis. OPN and P21 positivity was remarkably correlated with the metastasis in PHC(P<0.05). The positive-expression cases of both OPN and P21 in primary hepatic carcinoma tissued were 35,out of them, 26 cases had metastasis,however,in the negative-expression case of both OPN and P21, only 1 case had metastasis. Both OPN and P21 positive-expression was remarkably related with the metastasis in primary hepatic carcinoma(P<0.05). The positive-expression of OPN and P21 weren't related to the size of tumor, level of α-fetoprotein, HBsAg, gender, age and stage of tumor,while they were correlated with metastasis of tumor.Conclusion Both OPN and P21 are significantly related to the metastasis of PHC and over-expression of both OPN and P21 has some predicting significance of metastasis of primary hepatic carcinoma.
出处 《实用肝脏病杂志》 CAS 2005年第2期73-76,共4页 Journal of Practical Hepatology
基金 安徽省自然科学基金 (编号 :0 0 0 4 4 32 2和 0 1 0 4 371 6 )资助
  • 相关文献

参考文献14

  • 1Weber GF, Ashkar S, Cantor H, et al. Receptor-ligand interaction between CD44 and osteopontin(Eta-1). Science, 1996, 271:509- 512
  • 2Denhardt DT, Giachelli CM , Rittling SR. Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol, 2001,41:723 - 749
  • 3Wu Y, Denhardt DT, Rittling SR. Osteopontin is required for full expression of the transformed phenotype by the ras oncogene, Br J Cancer. 2000,83(2) : 156 - 63
  • 4Noriharu S, Toshimitsu U, Shigeyuki K, et al. Vascular endothelial growth factor and osteopontin in stage 1 lung adenocarcinoma. Am J Respir Crit Care Med, 1999,160: 1269- 1273
  • 5Oates A J, Barraclough R, Rudl PS, et al. The identification of osteopontin as a metastasis- related gene product in a rodent mammary tumour model. Oncogene, 1996, 13 : 97 - 104
  • 6Urquidi V , Sloan D , Kawai K, et al. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clin Cancer Res,2002,8:61 -74
  • 7Pan HW, Ou YH, Peng SY, et al. Overexpression of osteopontin isassociated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Cancer. 2003,98( 1 ) : 119 - 27
  • 8Masahiro G, Michiie S, Kengo K, et al. Overexpression of osteopontin in hepatocellular carcinoma. Pathol Inter, 2002,52 : 19 - 24
  • 9Behrend El, Craig AM, Wilson SM, et al. Reduced malignancy of ras-transformed NIH3T3 cells expressing antisense osteopontin RNA. Cancer Res, 1994,54: 832 - 837
  • 10ZuberJ, Tchernitsa OI, Hinzmann B, et al. A genome-wide survey of RAS transformation targets. Net Genet,2000,24(2) : 144 - 152

二级参考文献5

  • 1Hill SA,Wilson S,Chambers AF.Clonal heterogeneity, experimental metastatic ability and p21 expression in H-ras-transformed NIH 3T3 cells[].Journal of the National Cancer Institute.1988
  • 2Weijzen S,Velders MP,Kast WM.Modulation of the immune response and tumor growth by activated ras[].Leukemia.1999
  • 3Birch M,Mitchell S,Hart IR.Isolation and characterization of human melonoma cell variants expressing high and low levels of CD44[].Cancer Research.1991
  • 4Busk M,Pytela R,Sheppard D.Characterization of the integrinαVβ6 as a fibronectin-binding protein[].Journal of Biological Chemistry.1992
  • 5Egan SE,Borere JJ,Jarolim L,et al.Co-regulation of metastatic and transforming activity of normal and mutant ras genes[].International Journal of Cancer.1989

共引文献3

同被引文献77

引证文献7

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部